| Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach B Giardine, J Borg, DR Higgs, KR Peterson, S Philipsen, D Maglott, ... Nature genetics 43 (4), 295-301, 2011 | 190 | 2011 |
| A European spectrum of pharmacogenomic biomarkers: implications for clinical pharmacogenomics C Mizzi, E Dalabira, J Kumuthini, N Dzimiri, I Balogh, N Başak, R Böhm, ... PloS one 11 (9), e0162866, 2016 | 124 | 2016 |
| Pharmacogenomic and pharmacotranscriptomic profiling of childhood acute lymphoblastic leukemia: paving the way to personalized treatment S Pavlovic, N Kotur, B Stankovic, B Zukic, V Gasic, L Dokmanovic Genes 10 (3), 191, 2019 | 54 | 2019 |
| Functional Analysis of the Role of the TPMT Gene Promoter VNTR Polymorphism in TPMT Gene Transcription B Zukic, M Radmilovic, M Stojiljkovic, N Tosic, F Pourfarzad, ... Pharmacogenomics 11 (4), 547-557, 2010 | 52 | 2010 |
| HLA genotyping in pediatric celiac disease patients B Stanković, N Radlović, Z Leković, D Ristić, V Radlović, G Nikčević, ... Bosnian Journal of Basic Medical Sciences 14 (3), 171, 2014 | 50 | 2014 |
| Variants in TPMT, ITPA, ABCC4 and ABCB1 genes as predictors of 6-mercaptopurine induced toxicity in children with acute lymphoblastic leukemia G Milosevic, N Kotur, N Krstovski, J Lazic, B Zukic, B Stankovic, D Janic, ... Journal of medical biochemistry 37 (3), 320, 2018 | 40 | 2018 |
| Expression pattern of long non-coding RNA growth arrest-specific 5 in the remission induction therapy in childhood acute lymphoblastic leukemia V Gasic, B Stankovic, B Zukic, D Janic, L Dokmanovic, N Krstovski, J Lazic, ... Journal of medical biochemistry 38 (3), 292, 2019 | 38 | 2019 |
| Association of vitamin D, zinc and selenium related genetic variants with COVID-19 disease severity N Kotur, A Skakic, K Klaassen, V Gasic, B Zukic, V Skodric-Trifunovic, ... Frontiers in Nutrition 8, 689419, 2021 | 37 | 2021 |
| Genomic Variation in the MAP3K5 Gene is Associated with β-Thalassemia Disease Severity and Hydroxyurea Treatment Efficacy C Tafrali, A Paizi, J Borg, M Radmilovic, M Bartsakoulia, E Giannopoulou, ... Pharmacogenomics 14 (5), 469-483, 2013 | 35 | 2013 |
| Molecular genetics and genotype-based estimation of BH4-responsiveness in Serbian PKU patients: spotlight on phenotypic implications of p. L48S M Djordjevic, K Klaassen, A Sarajlija, N Tosic, B Zukic, B Kecman, ... JIMD Reports–Case and Research Reports, 2012/6, 49-58, 2013 | 35 | 2013 |
| Functional analysis of a novel KLF1 gene promoter variation associated with hereditary persistence of fetal hemoglobin M Radmilovic, B Zukic, MS Petrovic, M Bartsakoulia, B Stankovic, N Kotur, ... Annals of hematology 92, 53-58, 2013 | 34 | 2013 |
| 6-Mercaptopurine influences TPMT gene Transcription in a TPMT Gene Promoter Variable Number of Tandem Repeats-Dependent Manner N Kotur, B Stankovic, K Kassela, M Georgitsi, A Vicha, I Leontari, ... Pharmacogenomics 13 (3), 283-295, 2012 | 34 | 2012 |
| Functional prediction and comparative population analysis of variants in genes for proteases and innate immunity related to SARS-CoV-2 infection K Klaassen, B Stankovic, B Zukic, N Kotur, V Gasic, S Pavlovic, ... Infection, Genetics and Evolution 84, 104498, 2020 | 33 | 2020 |
| Pharmacogenomic markers of methotrexate response in the consolidation phase of pediatric acute lymphoblastic leukemia treatment N Kotur, J Lazic, B Ristivojevic, B Stankovic, V Gasic, L Dokmanovic, ... Genes 11 (4), 468, 2020 | 31 | 2020 |
| Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers T Karan-Djurasevic, V Palibrk, B Zukic, V Spasovski, I Glumac, M Colovic, ... Medical Oncology 30, 1-5, 2013 | 30 | 2013 |
| Tpmt Gene Expression is Increased During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia Patients in a TPMT Gene Promoter Variable … N Kotur, L Dokmanovic, D Janic, B Stankovic, N Krstovski, N Tosic, ... Pharmacogenomics 16 (15), 1701-1712, 2015 | 28 | 2015 |
| Transcriptional regulation and pharmacogenomics M Georgitsi, B Zukic, S Pavlovic, GP Patrinos Pharmacogenomics 12 (5), 655-673, 2011 | 27 | 2011 |
| Pharmacogenomic markers of glucocorticoid response in the initial phase of remission induction therapy in childhood acute lymphoblastic leukemia V Gasic, B Zukic, B Stankovic, D Janic, L Dokmanovic, J Lazic, N Krstovski, ... Radiology and oncology 52 (3), 296, 2018 | 25 | 2018 |
| The influence of novel transcriptional regulatory element in intron 14 on the expression of Janus kinase 2 gene in myeloproliferative neoplasms V Spasovski, N Tosic, G Nikcevic, M Stojiljkovic, B Zukic, M Radmilovic, ... Journal of applied genetics 54, 21-26, 2013 | 24 | 2013 |
| Machine learning modeling from omics data as prospective tool for improvement of inflammatory bowel disease diagnosis and clinical classifications B Stankovic, N Kotur, G Nikcevic, V Gasic, B Zukic, S Pavlovic Genes 12 (9), 1438, 2021 | 23 | 2021 |
